Physician profile
John L Roring
NPI 1417185174
$1,048.68
in general payments reported to CMS, 2019-2025
14 companies · $15.46 in 2025
The $15.46 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2021: $61.88 · 2022: $182 · 2023: $275 · 2024: $388 · 2025: $15.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $242.22 | 2022-2023 | Nobelactive |
| Straumann USA LLC | $194.27 | 2019-2024 | |
| Carestream Dental, LLC | $145.13 | 2022 | |
| Patterson Companies, INC. | $136.91 | 2024 | |
| Align Technology, INC. | $125.80 | 2024 | Invisalign |
| Zimmer Biomet Holdings, INC. | $50.00 | 2021 | |
| Zimvie INC. | $31.69 | 2023 | |
| Biohorizons Implant Systems INC. | $26.39 | 2019 | |
| Voco America INC. | $20.44 | 2022 | |
| Ormco Corporation | $17.53 | 2023 | Spark |
| Solventum Corporation | $16.32 | 2024 | 3m Scotchbond, 3m Relyx, Clinpro 5000 |
| Envista Holdings Corporation | $15.46 | 2025 | Spark |
| Colgate Oral Pharmaceuticals, INC. | $14.64 | 2024 | |
| Dentsply Sirona INC | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Roring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.